The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential
Author:
Affiliation:
1. Department of Neurosurgery, Emory University, Atlanta, GA, USA
2. Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK
3. Neurosurgery section, Atlanta VA Medical Center, Decatur, GA, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1650019
Reference83 articles.
1. Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
2. Long-term survival with glioblastoma multiforme
3. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
4. Improved survival time trends for glioblastoma using the SEER 17 population-based registries
5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches;International Journal of Molecular Sciences;2024-05-26
2. Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response;Hypertension;2023-08
3. Azithromycin inhibits glioblastoma angiogenesis in mice via inducing mitochondrial dysfunction and oxidative stress;Cancer Chemotherapy and Pharmacology;2023-07-24
4. Carboxylated graphene quantum dots-mediated photothermal therapy enhances drug-membrane permeability, ROS production, and the immune system recruitment on 3D glioblastoma models;Cancer Nanotechnology;2023-02-24
5. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression;International Journal of Pharmaceutics;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3